ConductScience.org, home

Paper55646

Regional immunotherapy of lung cancer with intrapleural B.C.G.

McKneally MF and 2 others. Lancet, 1976. Cited by 166 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Regional immunotherapy of lung cancer with intrapleural B.C.G. Papers, record 55646. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/55646

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Regional immunotherapy of lung cancer with intrapleural B.C.G.
PubMed
Journal
Lancet
PubMed
Year
1976
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
166
iCite
Relative citation ratio, by iCite
5.9
iCite
Revised in PubMed
2019-06-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1McKneally MFM F
2Maver CC
3Kausel HWH W

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenocarcinomaMajor topic
BCG VaccineMajor topic
CarcinomaMajor topic
Carcinoma, Squamous CellMajor topic
Lung NeoplasmsMajor topic
Aged
Follow-Up Studies
Humans
Lymphatic Metastasis
Neoplasm Recurrence, Local
Pleura
Postoperative Care
Postoperative Complications
Prognosis
Prospective Studies
Time Factors

Source PubMed

Download CSV of topics

Cited by40

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 166 citations.

PMIDTitleJournalYearIn PapersSource
42437062BCG in the fight against cancer: exploring its applications in diverse tumour types and future directions.Ecancermedicalscience2026https://conductscience.org/library/papers/42437062PubMed
38693979Evaluation of the effects of postoperative pleural empyema on survival rates of patients after pneumonectomy due to non-small cell lung cancer.Kardiochir Torakochirurgia Pol2024https://conductscience.org/library/papers/38693979PubMed
36057634A trial of intra-pleural bacterial immunotherapy in malignant pleural mesothelioma (TILT) - a randomised feasibility study using the trial within a cohort (TwiC) methodology.Pilot Feasibility Stud2022https://conductscience.org/library/papers/36057634PubMed
26175924Assays for predicting and monitoring responses to lung cancer immunotherapy.Cancer Biol Med2015https://conductscience.org/library/papers/26175924PubMed
24278806Fever in Cancer Treatment: Coley's Therapy and Epidemiologic Observations.Glob Adv Health Med2012https://conductscience.org/library/papers/24278806PubMed
7466726Adjuvant immunotherapy with BCG in squamous cell bronchial carcinoma.Thorax1980https://conductscience.org/library/papers/7466726PubMed
7179188Autologous x-irradiated tumour cells and percutaneous BCG in operable lung cancer.Thorax1982https://conductscience.org/library/papers/7179188PubMed
7041323Five-year results of a controlled study of BCG immunotherapy after surgical resection in bronchogenic carcinoma.Thorax1982https://conductscience.org/library/papers/7041323PubMed
7028069Failure of specific active immunotherapy in lung cancer.Br J Cancer1981https://conductscience.org/library/papers/7028069PubMed
6966345Immunological approaches to cancer treatment.Jpn J Surg1980https://conductscience.org/library/papers/6966345PubMed
6762247Immunological studies in a double blind randomized trial comparing intrapleural BCG against placebo in patients with resected stage I non-small cell lung cancer.Cancer Immunol Immunother1982https://conductscience.org/library/papers/6762247PubMed
6737402Adjuvant therapy in colorectal cancer.J R Soc Med1984https://conductscience.org/library/papers/6737402PubMed
6563941Experimental screening of BCG preparations produced for cancer immunotherapy: safety and immunostimulating and antitumor activity of four consecutively produced batches.Cancer Immunol Immunother1984https://conductscience.org/library/papers/6563941PubMed
6392656Eradication of microscopic metastases with intratumoral injection of bacillus Calmette-Guerin.Jpn J Surg1984https://conductscience.org/library/papers/6392656PubMed
6285089The management of lung cancer.Lung1982https://conductscience.org/library/papers/6285089PubMed
4036106Tuberculous peritonitis developing in a case of documented peritoneal carcinomatosis.West J Med1985https://conductscience.org/library/papers/4036106PubMed
2982882Small-cell lung cancer and immunochemotherapy with Propionibacterium granulosum KP 45.J Cancer Res Clin Oncol1985https://conductscience.org/library/papers/2982882PubMed
2938735Effects of inflammation products on immune systems. Lysophosphatidylcholine stimulates macrophages.Cancer Immunol Immunother1986https://conductscience.org/library/papers/2938735PubMed
2516851Effect of combined intrapleural administration of Lactobacillus casei (LC9018) and adriamycin on experimental malignant pleurisy in mice.Jpn J Cancer Res1989https://conductscience.org/library/papers/2516851PubMed
2414458Update in cancer chemotherapy, Part III: Lung cancer, Part 1.J Natl Med Assoc1985https://conductscience.org/library/papers/2414458PubMed

See all 40 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/55646

GET https://conductscience.org/api/papers/v1/55646/cited_by?page=2